Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of Antibody-Fragment-Producing Rice for Neutralization of Human Norovirus.
Sasou A, Yuki Y, Kurokawa S, Sato S, Goda Y, Uchida M, Matsumoto N, Sagara H, Watanabe Y, Kuroda M, Sakon N, Sugiura K, Nakahashi-Ouchida R, Ushijima H, Fujihashi K, Kiyono H. Sasou A, et al. Front Plant Sci. 2021 Feb 23;12:639953. doi: 10.3389/fpls.2021.639953. eCollection 2021. Front Plant Sci. 2021. PMID: 33868338 Free PMC article.
A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci.
Nakahashi-Ouchida R, Uchida Y, Yuki Y, Katakai Y, Yamanoue T, Ogawa H, Munesue Y, Nakano N, Hanari K, Miyazaki T, Saito Y, Umemoto S, Sawada SI, Mukerji R, Briles DE, Yasutomi Y, Akiyoshi K, Kiyono H. Nakahashi-Ouchida R, et al. Vaccine. 2021 Jun 8;39(25):3353-3364. doi: 10.1016/j.vaccine.2021.04.069. Epub 2021 May 17. Vaccine. 2021. PMID: 34016473 Free article.
Mucosal vaccines: wisdom from now and then.
Kiyono H, Yuki Y, Nakahashi-Ouchida R, Fujihashi K. Kiyono H, et al. Int Immunol. 2021 Nov 25;33(12):767-774. doi: 10.1093/intimm/dxab056. Int Immunol. 2021. PMID: 34436595 Free PMC article. Review.
Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
Yuki Y, Nojima M, Kashima K, Sugiura K, Maruyama S, Kurokawa S, Yamanoue T, Nakahashi-Ouchida R, Nakajima H, Hiraizumi T, Kohno H, Goto E, Fujihashi K, Kiyono H. Yuki Y, et al. Among authors: nakahashi ouchida r. Vaccine. 2022 May 26;40(24):3372-3379. doi: 10.1016/j.vaccine.2022.04.051. Epub 2022 Apr 26. Vaccine. 2022. PMID: 35484039 Free article. Clinical Trial.
Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial.
Yuki Y, Nojima M, Hosono O, Tanaka H, Kimura Y, Satoh T, Imoto S, Uematsu S, Kurokawa S, Kashima K, Mejima M, Nakahashi-Ouchida R, Uchida Y, Marui T, Yoshikawa N, Nagamura F, Fujihashi K, Kiyono H. Yuki Y, et al. Among authors: nakahashi ouchida r. Lancet Microbe. 2021 Sep;2(9):e429-e440. doi: 10.1016/S2666-5247(20)30196-8. Epub 2021 Jun 25. Lancet Microbe. 2021. PMID: 35544149 Free article. Clinical Trial.
Induction of Mucosal IgA-Mediated Protective Immunity Against Nontypeable Haemophilus influenzae Infection by a Cationic Nanogel-Based P6 Nasal Vaccine.
Nakahashi-Ouchida R, Mori H, Yuki Y, Umemoto S, Hirano T, Uchida Y, Machita T, Yamanoue T, Sawada SI, Suzuki M, Fujihashi K, Akiyoshi K, Kurono Y, Kiyono H. Nakahashi-Ouchida R, et al. Front Immunol. 2022 Jul 6;13:819859. doi: 10.3389/fimmu.2022.819859. eCollection 2022. Front Immunol. 2022. PMID: 35874779 Free PMC article.
17 results